scispace - formally typeset
Y

Yanjiao Zhou

Researcher at University of Connecticut Health Center

Publications -  78
Citations -  24919

Yanjiao Zhou is an academic researcher from University of Connecticut Health Center. The author has contributed to research in topics: Microbiome & Medicine. The author has an hindex of 35, co-authored 65 publications receiving 21151 citations. Previous affiliations of Yanjiao Zhou include St. Louis Children's Hospital & Tianjin Medical University.

Papers
More filters
Journal ArticleDOI

Structure, function and diversity of the healthy human microbiome

Curtis Huttenhower, +253 more
- 14 Jun 2012 - 
TL;DR: The Human Microbiome Project Consortium reported the first results of their analysis of microbial communities from distinct, clinically relevant body habitats in a human cohort; the insights into the microbial communities of a healthy population lay foundations for future exploration of the epidemiology, ecology and translational applications of the human microbiome as discussed by the authors.
Journal Article

Structure, function and diversity of the healthy human microbiome

Curtis Huttenhower, +247 more
- 01 Jun 2012 - 
TL;DR: The Human Microbiome Project has analysed the largest cohort and set of distinct, clinically relevant body habitats so far, finding the diversity and abundance of each habitat’s signature microbes to vary widely even among healthy subjects, with strong niche specialization both within and among individuals.
Journal ArticleDOI

A framework for human microbiome research

Barbara A. Methé, +253 more
- 14 Jun 2012 - 
TL;DR: The Human Microbiome Project (HMP) Consortium has established a population-scale framework which catalyzed significant development of metagenomic protocols resulting in a broad range of quality-controlled resources and data including standardized methods for creating, processing and interpreting distinct types of high-throughput metagenomics data available to the scientific community as mentioned in this paper.
Journal ArticleDOI

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

TL;DR: The power of whole-genome sequencing is applied to identify steps in the evolution of multidrug resistance in isogenic S. aureus isolates recovered periodically from the bloodstream of a patient undergoing chemotherapy with vancomycin and other antibiotics.